Salpingo-Oophorectomy Clinical Trials

Clinical trials related to Salpingo-Oophorectomy Procedure

Predicting the Pain Outcome of Surgery for Endometriosis

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Observational
SUMMARY

This study aims to determine whether the investigators can predict who will get benefit in terms of their pain from surgery for more severe forms of endometriosis. The investigators will use brain imaging to explore this, as it allows meaningful results from a smaller sample of people than if questionnaires alone were relied on.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 50
Healthy Volunteers: f
View:

• willing and able to give informed consent

• aged between 18 and 50 years of age

• female or born female

• diagnosed with stage III or IV endometriosis by scan (MRI or USS) or previous surgery

• surgical treatment of severe endometriosis planned (surgical procedure at discretion of operating surgeon)

• reports pelvic pain of ≥4/10 (measured using a 0 - 10 numerical rating scale asking about the participant's worst pelvic pain associated with their endometriosis)

• reasonably fluent in English

• in the Investigator's opinion, is able and willing to comply with all study requirements

• willing to allow his or her General Practitioner and consultant to be notified of participation in the study

Locations
Other Locations
United Kingdom
Oxford University Hospitals Foundation Trust
RECRUITING
Oxford
Contact Information
Primary
Katy Vincent, DPhil, FRCOG
katy.vincent@wrh.ox.ac.uk
00 44 1865 220024
Backup
Kirralise Hansford, PhD
kirralise.hansford@wrh.ox.ac.uk
Time Frame
Start Date: 2025-12
Estimated Completion Date: 2028-08
Participants
Target number of participants: 100
Treatments
PrePOSE cohort
Women aged 18 - 50 years, with stage III or IV endometriosis, reporting pelvic pain of ≥4/10 and planned for surgical treatment of their endometriosis
Related Therapeutic Areas
Sponsors
Collaborators: Endometriosis UK
Leads: University of Oxford

This content was sourced from clinicaltrials.gov